UBERTI FOPPA, CATERINA
 Distribuzione geografica
Continente #
AS - Asia 3.302
NA - Nord America 1.900
EU - Europa 1.670
SA - Sud America 941
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 2
Totale 7.856
Nazione #
US - Stati Uniti d'America 1.809
SG - Singapore 1.381
CN - Cina 971
BR - Brasile 780
SE - Svezia 595
HK - Hong Kong 493
IT - Italia 280
VN - Vietnam 221
RU - Federazione Russa 191
RO - Romania 168
DE - Germania 115
AR - Argentina 70
FI - Finlandia 60
GB - Regno Unito 58
IN - India 55
NL - Olanda 52
CA - Canada 50
BD - Bangladesh 40
EC - Ecuador 31
IE - Irlanda 28
MX - Messico 28
PL - Polonia 25
ID - Indonesia 24
JP - Giappone 22
AT - Austria 21
CO - Colombia 17
ES - Italia 17
FR - Francia 17
TR - Turchia 16
UA - Ucraina 16
ZA - Sudafrica 16
IQ - Iraq 15
LT - Lituania 13
PY - Paraguay 12
VE - Venezuela 12
CL - Cile 10
UZ - Uzbekistan 10
MA - Marocco 7
AE - Emirati Arabi Uniti 6
PH - Filippine 6
SA - Arabia Saudita 6
DO - Repubblica Dominicana 5
IL - Israele 5
KE - Kenya 5
MY - Malesia 5
PK - Pakistan 5
PE - Perù 4
TN - Tunisia 4
DZ - Algeria 3
EG - Egitto 3
HR - Croazia 3
JM - Giamaica 3
KG - Kirghizistan 3
NP - Nepal 3
SN - Senegal 3
SV - El Salvador 3
UY - Uruguay 3
BO - Bolivia 2
CH - Svizzera 2
EU - Europa 2
IR - Iran 2
LB - Libano 2
MD - Moldavia 2
PS - Palestinian Territory 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
Totale 7.856
Città #
Singapore 593
Hong Kong 492
Dallas 342
Ashburn 220
Shanghai 217
Hefei 207
Lawrence 190
Princeton 190
Beijing 127
Milan 107
New York 96
Ho Chi Minh City 83
Los Angeles 82
Moscow 80
São Paulo 72
Helsinki 48
Hanoi 39
Boardman 31
Nuremberg 29
Dublin 28
Guangzhou 26
Munich 25
Rio de Janeiro 25
Rome 25
Santa Clara 22
Tokyo 22
Warsaw 22
Denver 21
Pune 21
Seattle 20
London 19
Orem 19
Montreal 17
Brooklyn 15
Curitiba 15
Stockholm 15
Dronten 14
Haiphong 14
Toronto 14
Chennai 13
Johannesburg 13
Poplar 13
Chicago 12
Phoenix 12
Shenzhen 12
Atlanta 11
Belo Horizonte 11
Boston 11
Da Nang 11
Guayaquil 10
Hangzhou 10
Tashkent 10
Turku 10
Brasília 9
Contagem 9
Goiânia 9
Mexico City 9
Quito 9
Washington 9
Buenos Aires 8
Cesano Boscone 8
Dhaka 8
Porto Alegre 8
The Dalles 8
Ankara 7
Campinas 7
Houston 7
Manchester 7
Reston 7
Salvador 7
Sorocaba 7
Vienna 7
Columbus 6
San Francisco 6
Vitória 6
Amsterdam 5
Biên Hòa 5
Can Tho 5
Caracas 5
Falkenstein 5
Indaiatuba 5
Ipatinga 5
Kassel 5
Ribeirão Preto 5
Riyadh 5
Tianjin 5
Vittoria 5
Vitória da Conquista 5
Wuxi 5
Aracaju 4
Bogotá 4
Bình Dương 4
Caruaru 4
Caxias do Sul 4
Changsha 4
Concord 4
Council Bluffs 4
Cuenca 4
Erbil 4
Florence 4
Totale 4.085
Nome #
Monkeypox in a patient with undifferentiated connective tissue disease 217
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 133
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 109
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
Marked Decrease in Lymphocyte Count in HIV/Hepatitis C Virus (HCV)-Coinfected Patients with Advanced Liver Disease during Anti-HCV Treatment with Direct-Acting Antiviral Regimens Including Ribavirin 80
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 80
Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy 78
HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts 74
Condom use with steady partners among heterosexual people living with HIV in Europe: Testing the information-motivation-behavioral skills model 73
HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study) 72
Cardiac implantable electronic device infections: impact of initiation of antimicrobial treatment before or after device removal on microbiological yield 71
A Nonparametric Procedure for Defining a New Humoral Immunologic Profile in a Pilot Study on HIV Infected Patients 71
Post-neurosurgical Nocardia meningoventriculitis: a case report and review of the literature 70
Association between the presence of CCR5-specific antibodies and long term non progression 68
Characterization of GBV-C infection in HIV-1 infected patients 64
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols 64
A study of cellular immunity in newborns after prevention of respiratory distress syndrome (RDS). 63
Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement. 61
Anti-hepatitis C virus treatment may prevent the progression of liver fibrosis in non-responder human immunodeficiency virus/hepatitis C virus coinfected patients 61
Mpox neutralising antibodies at 6 months from mpox infection or MVA-BN vaccination: a comparative analysis 59
A RETROSPECTIVE STUDY OF PRIMARY AND MAINTENANCE THERAPY OF TOXOPLASMIC ENCEPHALITIS WITH ORAL CLINDAMYCIN AND PYRIMETHAMINE 58
Experiences with immunomodulant agents in HIV infections 58
ABC of AIDS: Treatment of infections and antiviral agents 57
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 56
Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: A Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians 55
Abundant and superficial expression of C-type lectin receptors in ectocervix of women at risk of HIV infection. 55
Case Report: Lenvatinib for the treatment of recurrent hepatocellular carcinoma in people living with HIV: a report of two cases 54
Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment 54
Hepatic safety profile of darunavir with low-dose ritonavir (DRV/r) in HIV/HCV coinfected and HIV monoinfected patients 53
Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients? 53
A liquid chromatography-tandem mass spectrometry method for simultaneous determination of simeprevir, daclatasvir, sofosbuvir, and GS-331007 applied to a retrospective clinical pharmacological study 52
Longitudinal evaluation of occult Hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption 51
Carri, S; Fantini, R; Ferrara, G; Luppi F; Marchionni A; Pardi Roberto; Richeldi L; Roversi P; Uberti Foppa Caterina Capitolo 18 - Influenza in Medicina interna sistematica 51
Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman 50
Long-term effect of highly active antiretroviral therapy on cervical lesions in HIV-positive women. 50
Combination of High-Dose Daptomycin and Ceftriaxone for Cardiac Implantable Electronic Device Infections: A 10-Year Experience 49
Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients 49
Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma 49
Survival in People Living with HIV with or without Recurrence of Hepatocellular Carcinoma after Invasive Therapy 48
Immunological status in heroin addicts: effects of methadone maintenance treatment 48
60PV related lesions in HIV positive subjects on HAART: Study of viral markers of cervical neoplasia progression 48
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients 48
Incidence and risk factors of neurosurgical site infections: results of a prospective multicenter cohort study on 6359 surgeries 48
Uberti Foppa C, Gaiera G, Nunzi E, Spagnuolo V Capitolo 101 Infezioni sistemiche in: Rugarli Medicina interna sistematica 48
European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis: Report from Italy 47
Early diagnosis of HIV infection in infants 47
Pediatric cancer care management during the COVID-19 pandemic: a review of the literature and a single-centre real-life experience of an Italian pediatric oncology unit 46
Evolution of the E2 region of hepatitis C virus in an infant infected by mother-to-infant transmission 46
Brief Report: Outcome of Acute Hepatitis B Virus Infection in HIV-1-Infected Patients: Possible Factors Associated with Resolution or Chronicity 46
Uberti Foppa C, Gaiera G; Novati R Cap. 94 - Infezioni sistemiche in Rugarli C Medicina interna sistematica. Con CD-ROM 46
Uberti Foppa C - Capitolo 18 - Influenza in Rugarli. Medicina interna sistematica 46
Saliva molecular testing for SARS-CoV-2: Simplifying the diagnosis without losing accuracy 46
Raised serum beta 2 microglobulin levels in different stages of human immunodeficiency virus infection 45
INCREASED RISK OF DEATH AMONG HIV/HCV CO-INFECTED PATIENTS WITH NON-HODGKIN'S LYMPHOMA 45
Child desire in women and men living with HIV attending HIV outpatient clinics: Evidence from a European multicentre study 45
Impact of HAART on liver histology of HIV/HCV coinfected patients 44
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 44
Role of PMN's candidicidal activity in the pathogenesis of AIDS-related systemic candidiases 42
Immune response to hepatitis B vaccination in HIV-positive individuals with isolated antibodies against hepatitis B core antigen: Results of a prospective Italian study 42
Short Communication: Decreased Plasma Calcitonin Gene-Related Peptide as a Novel Biomarker for HIV-1 Disease Progression 42
Reduced raltegravir clearance in HIV-infected liver transplant recipients: An unexpected interaction with immunosuppressive therapy? 42
Profiling Antibody Response Patterns in COVID-19: Spike S1-Reactive IgA Signature in the Evolution of SARS-CoV-2 Infection 42
A prospective italian study on baseline NS3 and NS5A resistance to direct-acting antivirals in a real-world setting of HIV-1/HCV coinfected patients and association with treatment outcome 41
Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy 40
Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease 40
Morphogenesis, evolution and prognostic significance of lymphatic tissue lesions in HIV infection 40
Clinical and epidemiological aspects of the first 50 cases of AIDS in Milan 40
Virological and Serological Discordant Profiles in COVID-19 Pneumonia: Two Atypical Clinical Cases 40
Clinical and immunological aspects of HIV infection in drug addicts 39
Compartmentalization of resistance-associated substitutions in hiv/hcv-infected patients: Possible correlation with infecting hcv genotype 39
Long-lasting CCR5 internalization by antibodies in a subset of long-term non progressors: a possible protective effect against disease progression 38
Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. 38
Uberti Foppa C Capitolo 18 - Influenza in Medicina interna sistematica. Con CD-ROM 38
Risk of HIV-related diseases in heterosexuals importing infection from Zaire 37
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy 37
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 37
LIVER STEATOSIS IN HIV/HCV COINFECTED AND HCV-MONOINFECTED PATIENTS: AN HISTOLOGICAL COMPARISON 36
Risk of human immunodeficiency virus infection in multiple transfused patients 36
HIGH FREQUENCY OF TORQUE TENO VIRUS (TTV) INFECTION IN HIV-EXPOSED SERONEGATIVE INDIVIDUALS (ESN) AND THEIR HIV-POSITIVE SEXUAL PARTNERS 36
Febbre di origine sconosciuta 36
Patients' satisfaction with sexual and reproductive health services delivered in HIV clinics across European regions 36
Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy 36
Rugarli. Medicina interna sistematica 36
OPPORTUNISTIC INFECTIONS 36
LIVER HISTOLOGY IN HIV/HCV COINFECTED PATIENTS WITH PERSISTENTLY NORMAL SERUM AMINOTRANSFERASES 35
Mutations in the natural strains of NS3 protease domain that confer resistance to anti-HCV protease inhibitors in HIV/HCV coinfected patients 35
Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in HIV-positive women 35
Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients 35
Geographic Distribution of HCV-GT3 Subtypes and Naturally Occurring Resistance Associated Substitutions 35
Clinical Outcomes in Persons Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment 35
Treatment of invasive fungal infetions in immunocompromised patients with fluconazole 34
Human immunodeficiency virus (HIV) seropositivity in intravenous (i.v.) drug abusers in three cities of Italy: possible natural history of HIV infection in i.v. drug addicts in Italy 34
Liver function parameters in HIV/HCV co-infected patients treated with amprenavir and ritonavir and correlation with plasma levels 34
Infezioni sistemiche 34
Pulmonary candidiasis in a heroin addict: some remarks on its aetiology and pathogenesis 34
Factors influencing liver fibrosis and necroinflammation in HIV/HCV coinfection and HCV monoinfection 34
In vivo evidence that the cannabinoid receptor 2–63 RR variant is associated with the acquisition and/or expansion of HIV infection 34
Is shorter duration of antibiotic treatment feasible in patients with cardiac implantable electronic device infections undergoing device removal? A propensity-adjusted analysis of a 10-year retrospective cohort 34
Ribavirin therapy for chronic hepatitis C does not modify HIV viral load in HIV-1 positive patients under antiretroviral treatment 33
Epidemiological aspects of human immunodeficiency virus infection in Milan. 33
Totale 5.088
Categoria #
all - tutte 72.916
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.916


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 3 14 17 7 0 1 0
2021/2022117 0 0 0 53 4 9 9 12 10 4 4 12
2022/20231.070 434 257 65 4 13 110 52 70 45 12 7 1
2023/2024416 26 18 34 33 45 109 10 45 2 8 26 60
2024/20252.666 324 52 36 100 101 228 467 194 399 407 154 204
2025/20263.595 630 591 523 1.146 520 185 0 0 0 0 0 0
Totale 8.058